Compound Screening with Deep Learning for Neglected Diseases: Leishmaniasis
Smith, J.; Xu, H.; Li, X.; Yang, L.; Gutierrez Bugarin, J. M.
Show abstract
AO_SCPLOWBSTRACTC_SCPLOWDeep learning provides a tool for improving screening of candidates for drug re-purposing to treat neglected diseases. We show how a new pipeline can be developed to address the needs of repurposing for Leishmaniasis. In combination with traditional molecular docking techniques, this allows top candidates to be selected and analyzed, including for molecular descriptor similarity.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Retro Drug Design: From Target Properties to Molecular Structures 97%
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening 95%
- The use of a graph database is a complementary approach to a classical similarity search for identifying commercially available fragment merges 95%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- DrugForm-DTA: Towards real-world drug-target binding Affinity Model 95%
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 94%
- G-PLIP: Knowledge graph neural network for structure-free protein-ligand bioactivity prediction 93%
Similar papers in this journal
- DeepBindGCN: Integrating Molecular Vector Representation with Graph Convolutional Neural Networks for Accurate Protein-Ligand Interaction Prediction 95%
- Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform 94%
- Identifying Protein Features and Pathways Responsible for Toxicity using Machine learning, CANDO, and Tox21 datasets: Implications for Predictive Toxicology 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.